» Articles » PMID: 28325855

Pretreatment with the ALDH2 Agonist Alda-1 Reduces Intestinal Injury Induced by Ischaemia and Reperfusion in Mice

Overview
Journal Clin Sci (Lond)
Date 2017 Mar 23
PMID 28325855
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Many studies demonstrate that activation of aldehyde dehydrogenase 2 (ALDH2) protects against oxidative stress via detoxification of cytotoxic aldehydes, and could attenuate cardiac, cerebral, lung and renal ischaemia-reperfusion (I/R) injuries. However, the effect of ALDH2 in intestinal I/R is unknown. The present study was set up to determine whether an ALDH2 agonist, Alda-1, could alleviate intestinal injury after gut I/R. In a mouse model of intestinal I/R injury, histological grading, proinflammatory cytokines, oxidative stress, cellular apoptosis, chemokine contents, ALDH2 activity, 4-hydroxy--2-nonenal (4-HNE) and malondialdehyde (MDA) were evaluated. The results indicated that I/R treatment conferred elevation in pathological scores, proinflammatory cytokines, oxidative stress, cellular apoptosis and chemokine levels, accompanied by accumulated 4-HNE and MDA. No significant changes in ALDH2 activity were observed after I/R. However, Alda-1 pretreatment significantly decreased these injurious indicators, concomitant with up-regulated ALDH2 activity, and lessened 4-HNE and MDA accumulation. Taken together, our results implicate activation of ALDH2 by Alda-1 in the significant abatement intestinal I/R injury.

Citing Articles

Alda-1 attenuation of binge alcohol-caused atrial arrhythmias through a novel mechanism of suppressed c-Jun N-terminal Kinase-2 activity.

Yan J, Khanal S, Cao Y, Ricchiuti N, Nani A, Chen S J Mol Cell Cardiol. 2024; 197:11-19.

PMID: 39395657 PMC: 11664791. DOI: 10.1016/j.yjmcc.2024.10.003.


Targeting cell death pathways in intestinal ischemia-reperfusion injury: a comprehensive review.

Wang F, Huang H, Wei X, Tan P, Wang Z, Hu Z Cell Death Discov. 2024; 10(1):112.

PMID: 38438362 PMC: 10912430. DOI: 10.1038/s41420-024-01891-x.


Alda-1 ameliorates air embolism-induced acute lung injury.

Wu S, Chu S, Tang S, Pao H, Liao W Int J Immunopathol Pharmacol. 2023; 37:3946320231223005.

PMID: 38113877 PMC: 10734354. DOI: 10.1177/03946320231223005.


Activation of aldehyde dehydrogenase-2 improves ischemic random skin flap survival in rats.

Zhou T, Wang X, Wang K, Lin Y, Meng Z, Lan Q Front Immunol. 2023; 14:1127610.

PMID: 37441072 PMC: 10335790. DOI: 10.3389/fimmu.2023.1127610.


The Effects of Alda-1 Treatment on Renal and Intestinal Injuries After Cardiopulmonary Resuscitation in Pigs.

Yu Q, Gao J, Shao X, Lu W, Chen L, Jin L Front Med (Lausanne). 2022; 9:892472.

PMID: 35646953 PMC: 9133723. DOI: 10.3389/fmed.2022.892472.


References
1.
Grootjans J, Hodin C, de Haan J, Derikx J, Rouschop K, Verheyen F . Level of activation of the unfolded protein response correlates with Paneth cell apoptosis in human small intestine exposed to ischemia/reperfusion. Gastroenterology. 2010; 140(2):529-539.e3. DOI: 10.1053/j.gastro.2010.10.040. View

2.
Ben D, Yu X, Ji G, Zheng D, Lv K, Ma B . TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res. 2011; 174(2):326-33. DOI: 10.1016/j.jss.2010.12.005. View

3.
Gomes K, Bechara L, Lima V, Ribeiro M, Campos J, Dourado P . Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Int J Cardiol. 2014; 179:129-38. PMC: 4405147. DOI: 10.1016/j.ijcard.2014.10.140. View

4.
Fu S, Zhang H, Yang Z, Li T, Liu B, Lou Z . Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes. Naunyn Schmiedebergs Arch Pharmacol. 2013; 387(1):87-94. DOI: 10.1007/s00210-013-0922-8. View

5.
Deitch E . Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992; 216(2):117-34. PMC: 1242583. DOI: 10.1097/00000658-199208000-00002. View